MedPath

Comparison of two different routes of administration of Dexmedetomidine for post operative pain relief in patients receiving spinal anesthesia for lower limb orthopedic surgeries.

Phase 2/3
Not yet recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2022/10/046902
Lead Sponsor
Vydehi Institute of Medical sciences and Research Center
Brief Summary

This study will be conducted in Vydehi Indtuitute of medical sciences and Research Center recruiting patients posted for lower limb orthopedic surgeries. All patients will be receiving spinal anesthesia with Dexmedetomidine either as an adjuvant to spinal as 5 mcg intrathecally Or as an IV supplement at 0.5microgram per kg in 100 ml normal saline 15 minutes before spinal anesthesia.

The effect of this drug on the intervention will be measured in terms of onset and duration of motor and sensory blockade that the spinal anesthesia provides for these surgeries

The study will be conducted on 90 patients over a period of a year.

The results will he directed in the comparison of the two routes of administration of Dexmedetomidine as an adjuvant to spinal anesthesia in lower limb orthopedic surgeries.

The study shall also have secondary objectives of noting shivering sedation and any adverse effects due to the intervention.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria
    1. Patients undergoing lower Limb orthopaedic surgeries under Neuraxial blockade.
    1. Patients belonging to Americans Society of Anaesthesiologists physical status 1 and 2.
Exclusion Criteria
  1. Patients who did not consent 2) Allergies to Dexmedetomidine and Bupivacaine 3) Patients who underwent prolonged surgery requiring epidural activation 4) Emergency surgeries 5) Conversion to general Anesthesia 6) Localised infection at needle site 7) BMI> 35 kg/m2.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess and compare in both groups onset and duration of motor and sensory blockadeat 0th minute , 3rd, 6th, 9th, 12th, 15th, 30th, 60th minute then at 2nd ,4th, 6th ,10th , 12th and 24th hour
Secondary Outcome Measures
NameTimeMethod
Time to first rescue analgesia(Tramadol 50mg in 100ml normal saline)
Total rescue analgesic doses given in 24 hoursTime at which rescue Analgesia given is noted.
Sedation scoresIntra operative sedation scores until the surgery is complete is noted.
Incidence of shiveringIntra operative from the time of intervention to completion of surgery.
Adverse effects (if any)From the time of intervention up to 24 hours post procedure.

Trial Locations

Locations (1)

Vydehi Institute of Medical Sciences and Research Center

🇮🇳

Bangalore, KARNATAKA, India

Vydehi Institute of Medical Sciences and Research Center
🇮🇳Bangalore, KARNATAKA, India
DrAnup Suresh
Principal investigator
9036850860
anupsuresh28@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.